Published in Clin Neuropharmacol on April 06, 2007
Clinical features, pathophysiology, and treatment of levodopa-induced dyskinesias in Parkinson's disease. Parkinsons Dis (2012) 0.81
TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab (2009) 6.91
Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology (2005) 2.58
Skin nerve α-synuclein deposits: a biomarker for idiopathic Parkinson disease. Neurology (2014) 2.31
Severe impairment of complex I-driven adenosine triphosphate synthesis in leber hereditary optic neuropathy cybrids. Arch Neurol (2005) 2.17
TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab (2011) 2.17
Concern A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction. Proc Natl Acad Sci U S A (2004) 2.13
The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis. Gastroenterology (2004) 1.96
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians. Eur J Hum Genet (2005) 1.71
Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. Brain (2008) 1.69
Distribution, type, and origin of Parkin mutations: review and case studies. Mov Disord (2004) 1.54
Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J Biol Chem (2004) 1.50
Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy. Ann Neurol (2004) 1.40
Idebenone treatment in Leber's hereditary optic neuropathy. Brain (2011) 1.39
The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. Hepatology (2005) 1.38
A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis. J Pharmacol Exp Ther (2005) 1.30
Autosomal dominant lateral temporal epilepsy: clinical spectrum, new epitempin mutations, and genetic heterogeneity in seven European families. Epilepsia (2003) 1.27
Levetiracetam therapy in patients with brain tumour and epilepsy. J Neurooncol (2006) 1.26
Visual system involvement in patients with Friedreich's ataxia. Brain (2008) 1.25
Sleep disorders in patients with spinal cord injury. Sleep Med Rev (2013) 1.22
Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies. Brain (2006) 1.18
PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism. Eur J Hum Genet (2005) 1.17
Retracted A role for proteinase-activated receptor-1 in inflammatory bowel diseases. J Clin Invest (2004) 1.15
Strio-pallido-dentate calcinosis: a diagnostic approach in adult patients. Neurol Sci (2011) 1.15
Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. Brain (2009) 1.13
Supraciliary shunt in refractory glaucoma. Br J Ophthalmol (2011) 1.13
Anisakis pegreffi etiological agent of gastric infections in two Italian women. Foodborne Pathog Dis (2009) 1.13
Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis. J Pharmacol Exp Ther (2005) 1.11
Validation of the Italian version of the Movement Disorder Society--Unified Parkinson's Disease Rating Scale. Neurol Sci (2012) 1.06
Pharmacokinetics of levodopa. J Neurol (2010) 1.06
PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum. Hum Mutat (2008) 1.06
The ND1 gene of complex I is a mutational hot spot for Leber's hereditary optic neuropathy. Ann Neurol (2004) 1.05
Mutational analysis of parkin gene by denaturing high-performance liquid chromatography (DHPLC) in essential tremor. Parkinsonism Relat Disord (2004) 1.01
Arousal elicits exaggerated inhibition of sympathetic nerve activity in phobic syncope patients. Brain (2007) 1.00
Premutations in the FMR1 gene as a modifying factor in Parkin-associated Parkinson's disease? Mov Disord (2005) 1.00
Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association. J Neurol (2012) 0.99
Narcolepsy with cataplexy associated with holoprosencephaly misdiagnosed as epileptic drop attacks. Mov Disord (2010) 0.98
Unexpected gamma glutamyltransferase rise increase during levetiracetam monotherapy. Epileptic Disord (2010) 0.97
Btg2 enhances retinoic acid-induced differentiation by modulating histone H4 methylation and acetylation. Mol Cell Biol (2006) 0.97
Mitochondrial DNA nucleotide changes C14482G and C14482A in the ND6 gene are pathogenic for Leber's hereditary optic neuropathy. Ann Neurol (2002) 0.95
Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs. Epilepsia (2006) 0.95
miRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time pCR. PLoS One (2012) 0.93
Lateralizing value of the auditory aura in partial seizures. Epilepsia (2006) 0.93
Cooperation between aspirin-triggered lipoxin and nitric oxide (NO) mediates antiadhesive properties of 2-(Acetyloxy)benzoic acid 3-(nitrooxymethyl)phenyl ester (NCX-4016) (NO-aspirin) on neutrophil-endothelial cell adherence. J Pharmacol Exp Ther (2004) 0.93
Small nerve fiber involvement in patients referred for fibromyalgia. Muscle Nerve (2014) 0.93
Small fiber neuropathy in female patients with fabry disease. Muscle Nerve (2010) 0.92
The R98Q variation in DJ-1 represents a rare polymorphism. Ann Neurol (2004) 0.92
Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference. PLoS One (2013) 0.92
Defective mitochondrial adenosine triphosphate production in skeletal muscle from patients with dominant optic atrophy due to OPA1 mutations. Arch Neurol (2010) 0.91
Benign tremulous parkinsonism in a patient with dardarin mutation. Mov Disord (2009) 0.90
Adult Alexander's disease without leukoencephalopathy. Ann Neurol (2005) 0.90
Biochemical-clinical correlation in patients with different loads of the mitochondrial DNA T8993G mutation. Arch Neurol (2002) 0.89
A de novo LGI1 mutation in sporadic partial epilepsy with auditory features. Ann Neurol (2004) 0.88
Immunoproteasome in cancer and neuropathologies: a new therapeutic target? Curr Pharm Des (2013) 0.88
Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. Ther Drug Monit (2004) 0.87
Prognostic factors in patients with mesial temporal lobe epilepsy. Epilepsia (2009) 0.87
Unveiling hidden features of orphan nuclear receptors: the case of the small heterodimer partner (SHP). J Mol Graph Model (2005) 0.87
Does the prion protein gene 129 codon polymorphism influence sleep? Evidence from a fatal familial insomnia kindred. Clin Neurophysiol (2002) 0.87
Atypical late-onset hereditary spastic paraplegia with thin corpus callosum due to novel compound heterozygous mutations in the SPG11 gene. J Neurol (2014) 0.87
A novel in-frame 18-bp microdeletion in MT-CYB causes a multisystem disorder with prominent exercise intolerance. Hum Mutat (2014) 0.86
Brain diffusion-weighted imaging in Friedreich's ataxia. Mov Disord (2011) 0.86
Habituation of sympathetic sudomotor and vasomotor skin responses: neural and non-neural components in healthy subjects. Clin Neurophysiol (2005) 0.86
Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.86
Epilepsy in primary cerebral tumors: the characteristics of epilepsy at the onset (results from the PERNO study--Project of Emilia Romagna Region on Neuro-Oncology). Epilepsia (2013) 0.85
Low penetrance of autosomal dominant lateral temporal epilepsy in Italian families without LGI1 mutations. Epilepsia (2013) 0.85
Targeting fusion protein/corepressor contact restores differentiation response in leukemia cells. EMBO J (2005) 0.85
Simple and validated HPLC-UV analysis of levetiracetam in deproteinized plasma of patients with epilepsy. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.84
Variation in lamotrigine plasma concentrations with hormonal contraceptive monthly cycles in patients with epilepsy. Epilepsia (2006) 0.84
Anhidrosis in multiple system atrophy: a preganglionic sudomotor dysfunction? Mov Disord (2008) 0.84
Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease. Radiology (2013) 0.84
Peripheral autonomic neuropathy: diagnostic contribution of skin biopsy. J Neuropathol Exp Neurol (2012) 0.84
MRI and SPECT of midbrain and striatal degeneration in fragile X-associated tremor/ataxia syndrome. J Neurol (2007) 0.83
Back door modulation of the farnesoid X receptor: design, synthesis, and biological evaluation of a series of side chain modified chenodeoxycholic acid derivatives. J Med Chem (2006) 0.83
Cybrid studies establish the causal link between the mtDNA m.3890G>A/MT-ND1 mutation and optic atrophy with bilateral brainstem lesions. Biochim Biophys Acta (2012) 0.83
A novel pedigree with familial cortical myoclonic tremor and epilepsy (FCMTE): clinical characterization, refinement of the FCMTE2 locus, and confirmation of a founder haplotype. Epilepsia (2013) 0.82
Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease. Clin Neuropharmacol (2004) 0.82
Expression of SMRTbeta promotes ligand-induced activation of mutated and wild-type retinoid receptors. Blood (2004) 0.82